| Apr 8 2019 |
CBD Update: FDA Issues Statement, Calls Public Hearing, and Announces Warning Letters on Products Containing Cannabis and its Components |
Robinson & Cole LLP |
| Apr 8 2019 |
Recent Case Provides Important Lessons For Buyers Acquiring Unionized Businesses |
Squire Patton Boggs (US) LLP |
| Apr 8 2019 |
OCR Publishes Recommendations to Prepare for Cybersecurity Threats |
Dinsmore & Shohl LLP |
| Apr 8 2019 |
Over 50 VA Nursing Homes Found to Have Caused “Actual Harm” to Veterans |
Stark & Stark |
| Apr 8 2019 |
Congress Keeping its Focus on Drug Costs |
Mintz |
| Apr 8 2019 |
Latest FDA Data Show Foodborne Pathogens in Fresh Herbs, Guacamole, and Processed Avocado; The Source of a New Multistate E. coli O103 Outbreak Remains a Mystery |
Keller and Heckman LLP |
| Apr 5 2019 |
Kentucky and Arkansas Work Requirements Blocked |
McDermott Will & Schulte LLP |
| Apr 5 2019 |
Ohio Workers’ Compensation System Does Its Part to Mitigate the Opioid Epidemic’s Impact on the State’s Workforce (US) |
Squire Patton Boggs (US) LLP |
| Apr 5 2019 |
Utah Medicaid 1115 Waiver Summary |
McDermott Will & Schulte LLP |
| Apr 5 2019 |
New Hazardous Waste Pharmaceutical Rule Imposes New Obligations on Health Care Providers |
Van Ness Feldman LLP |
| Apr 5 2019 |
McDermottPlus Check-Up: April 5, 2019 |
McDermott Will & Schulte LLP |
| Apr 5 2019 |
Beltway Buzz, April 5, 2019 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 5 2019 |
Just Culture–What Is It and Can It Minimize Patient Harm and Promote a Positive Workplace Culture? |
Jackson Lewis P.C. |
| Apr 4 2019 |
Update to Texas v. United States |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 4 2019 |
Complying with the California Consumer Privacy Act: Are Health Care Organizations "Home Free"? |
Mintz |
| Apr 4 2019 |
UPS and Matternet Team Up for Medical Supply Delivery Program |
Robinson & Cole LLP |
| Apr 4 2019 |
D.C. Circuit Strikes Down Key Parts of DOL’s Association Health Plan Rule |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 3 2019 |
340B Drug Ceiling Prices Now Available |
Dinsmore & Shohl LLP |
| Apr 3 2019 |
CMS’s New Part D Policies Address the Opioid Epidemic |
Mintz |
| Apr 3 2019 |
FDA Announces New Proposed Rule to Enhance Mammography Services |
Epstein Becker & Green, P.C. |
| Apr 3 2019 |
Bard Hernia Mesh MDL Moving Quickly |
Stark & Stark |
| Apr 3 2019 |
New Mexico Lawmakers Pass Bill for Telehealth Insurance Coverage, Payment Parity |
Foley & Lardner LLP |
| Apr 3 2019 |
March 2019 Regulatory Developments |
Giordano, Halleran & Ciesla, P.C. |
| Apr 2 2019 |
Healthcare Executives and Physician Leaders Discuss Latest Trends and Challenges in Delivering High-Quality Patient Care at AMGA’s 2019 Annual Conference |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 2 2019 |
What is the Deal With TDF Drug and Truvada Lawsuits? |
Stark & Stark |
| Apr 2 2019 |
Suspension of Benefits Issues [Podcast] |
Proskauer Rose LLP |
| Apr 2 2019 |
Maryland Proposes New Telehealth Psychology and Therapy Rules |
Foley & Lardner LLP |
| Apr 1 2019 |
Association Health Plan Regulations Invalidated |
Ballard Spahr LLP |
| Apr 1 2019 |
Some HIPAA Happenings |
Steptoe & Johnson PLLC |
| Mar 31 2019 |
Congress is back and busy. The Affordable Care Act (ACA) dominates the headlines. |
McDermott Will & Schulte LLP |
| Mar 30 2019 |
California Committee Includes Ultrafine Titanium Dioxide on Its Draft Priority 1 List for PEL Review |
Bergeson & Campbell, P.C. |
| Mar 29 2019 |
Minnesota Legislative Update, Part II: Bills to Watch |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 29 2019 |
Paid Family and Medical Leave Coming to Massachusetts |
Raymond Law Group LLC |
| Mar 29 2019 |
SCOTUS’ Warning On Manufacturers’ Duty To Warn |
Barnes & Thornburg LLP |
| Mar 29 2019 |
Learned Intermediary Doctrine Protects Pharmacy from Liability for Failure to Warn of Prescription Drug Side Effects |
Wilson Elser Moskowitz Edelman & Dicker LLP |
